Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eos Capital Partners is a leading private equity firm based in Athens, Greece, that specializes in providing growth capital to small and medium-sized enterprises (SMEs) with high expansion potential. The firm manages the Eos Hellenic Renaissance Fund and maintains a significant investment vertical in the healthcare and pharmaceutical sectors. Its healthcare portfolio includes major stakes in Euromedica, one of Greece's largest healthcare service providers, and Archigenis, a pharmaceutical company focused on manufacturing and distribution. Recently, the firm expanded its life sciences footprint by investing in Olyvos, a biotechnology and pharmaceutical company. Eos Capital Partners aims to drive value creation by supporting operational improvements and international growth for its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eos Capital Partners.